THE WHAT? Biomel, a company specialising in plant-based gut health products, has received a £5.5 million investment from Iris Ventures, a venture capital firm.
THE DETAILS The company has consistently grown since its 2017 launch, achieving over 80% annual organic growth and reaching operational profitability in 2020. The investment will be used primarily to enhance the production capacity at Biomel’s London facility to meet increasing consumer demand.
THE WHY? Montse Suarez, founder and managing partner of Iris, commends Biomel for being a leader in the plant-based gut health sector, noting that the company’s approach aligns with its vision of supporting extraordinary entrepreneurs. This investment validates Biomel’s business model and its potential to lead the functional gut health market.